Table 1 Comparison between MEPS and FMS regarding characteristics and disease-related parameters
From: Is middle East pain syndrome (MEPS) a variant of fibromyalgia syndrome or a distinct disease?
Studied Group Item | Middle East pain syndrome | Fibromyalgia | test | p-value | |
|---|---|---|---|---|---|
Sex: N. (%) - Female - Male | 36 (90.0) 4 (10.0) | 38 (95.0) 2 (5.0) | X2 = 0.72 | 0.3 | |
Age (Year) - Mean ± SD | 39.5 ± 8.7 | 36.4 ± 9.7 | t- test = 1.5 | 0.1 | |
Disease duration (Year) Mean ± SD | 4.25 ± 3.0 | 3.25 ± 1.98 | t- test = 1.7 | 0.08 | |
WPI - Mean ± SD | 13.6 ± 3.6 | 10.4 ± 3.1 | t- test = 4.1 | < 0.001 | |
SSS - Mean ± SD | 9.4 ± 1.3 | 8.4 ± 1.7 | t- test = 1.4 | 0.14 | |
FIQ - Mean ± SD | 72.9 ± 11.4 | 68.4 ± 12.7 | t- test = 1.6 | 0.09 | |
ESR mm -Mean ± SD | 22.45 ± 9.1 | 21.7 ± 7.9 | t- test = 0.39 | 0.6 | |
Vit D ng/ml -Mean ± SD | 9.08 ± 3.3 | 41.7 ± 6.5 | t- test = 24.9 | < 0.001 | |
PTH pg/ml -Mean ± SD | 77.13 ± 31.0 | 31.5 ± 9.8 | t- test = 8.8 | < 0.001 | |
CRP: (%) | 1 (2.5%) | 0 (0.0%) | X2 = 1.01 | 0.2 | |
RF: (%) | 4 (10.0%) | 1 (2.5%) | X2 = 1.01 | 0.1 | |
Anti-CCP: (%) | 0(0.0%) | 0(0.0%) | - | - | |